DAWN RH Newsletters – 2017

April 2017

DAWN support desk closures
Come and visit us at the BSR, Birmingham
Work Smarter: DAWN Version 7.9.66
Front Screen Tallies: Key patient information and checking your DAWN system is working smoothly
Expand your capabilities with DAWN
Increasing access to biosimilars and generics in Europe
Clinical patient registry recruitment and retention: a survey of patients in two chronic disease registries – RA and IBD
The acitretin and methotrexate combination therapy for psoriasis vulgaris achieves higher effectiveness and less liver fibrosis

March 2017

DAWN Regional User Workshop (London) – Proceedings Document
Come and visit us at the BSR
Reporting from your DAWN system
Boost team work with electronic referrals
Expand your capabilities with DAWN
RA Progresses More Slowly Now than 20 Years Ago
Biosimilars in Inflammatory Bowel Disease: Facts and Fears of Extrapolation
Novel Mechanism Induces Joint Destruction in Rheumatoid Arthritis

February 2017

Come and visit us at the BSR, Birmingham
DAWN Regional Workshop Success
Effectively record patient risks in DAWN
Resetting your DAWN password – help and guidance
New way to keep up to date and connect with 4S DAWN
Rheumatoid arthritis incidence is decreasing in the UK
Arthritis Drugs Get Nod From European Medicines Agency’s Committee for Medicinal Products for Human Use
Molecule Key to Joint Inflammation Identified, May Lead to Improved Arthritis Treatments

January 2017

Work Smarter – DAWN Version 7.9.61
Join us for the latest DAWN Regional User Group – South Region
Customer Support Resources
Expand your capabilities with DAWN
RA Treatment with TNF Inhibitors Greatly Decreases Heart Attack Risk, UK Study Finds
NICE backs use of UCB’s Cimzia, Novartis’ Cosentyx for psoriatic arthritis
MRI Predicts Joint Damage in Rheumatoid Arthritis
Rheumatoid Arthritis: Taking Aim at Comorbidities